scholarly journals Telmisartan, an Angiotensin II Type 1 Receptor Blocker, Improves Coronary Microcirculation and Insulin Resistance among Essential Hypertensive Patients without Left Ventricular Hypertrophy

2008 ◽  
Vol 31 (4) ◽  
pp. 615-622 ◽  
Author(s):  
Toshihide Hinoi ◽  
Yasuyuki Tomohiro ◽  
Shinji Kajiwara ◽  
Syusuke Matsuo ◽  
Yukihiro Fujimoto ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Angiotensin Ii ◽  
Left Ventricular Hypertrophy ◽  
Ventricular Hypertrophy ◽  
Left Ventricular ◽  
Coronary Microcirculation ◽  
Receptor Blocker ◽  
Hypertensive Patients

Candesartan, an angiotensin II receptor blocker, improves left ventricular hypertrophy and insulin resistance

Metabolism ◽  
2004 ◽  
Vol 53 (6) ◽  
pp. 777-781 ◽  
Author(s):  
Futoshi Anan ◽  
Naohiko Takahashi ◽  
Tatsuhiko Ooie ◽  
Masahide Hara ◽  
Hironobu Yoshimatsu ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Angiotensin Ii ◽  
Left Ventricular Hypertrophy ◽  
Ventricular Hypertrophy ◽  
Left Ventricular ◽  
Receptor Blocker ◽  
Angiotensin Ii Receptor Blocker ◽  
Angiotensin Ii Receptor

scholarly journals Blockade of Angiotensin II Type 1 Receptor Improves the Arrhythmia Morbidity in Mice With Left Ventricular Hypertrophy

2006 ◽  
Vol 70 (3) ◽  
pp. 335-341 ◽  
Author(s):  
Cuntai Zhang ◽  
Shinji Yasuno ◽  
Koichiro Kuwahara ◽  
Dimitar P. Zankov ◽  
Atsushi Kobori ◽  
...  
Keyword(s):  
Angiotensin Ii ◽  
Left Ventricular Hypertrophy ◽  
Ventricular Hypertrophy ◽  
Left Ventricular
Sign in / Sign up

Export Citation Format

Share Document